Literature DB >> 12629506

Interpretation of genetic association studies in complex disease.

H Campbell1, I Rudan.   

Abstract

Mesh：

Year:  2002        PMID： 12629506     DOI： 10.1038/sj.tpj.6500132

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  30 in total

1.  Genetic epidemiology and primary care.

Authors:  Blair H Smith; Graham C M Watt; Harry Campbell; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2006-03       Impact factor: 5.386

2.  Converging evidence does not support GIT1 as an ADHD risk gene.

Authors:  Marieke Klein; Monique van der Voet; Benjamin Harich; Kimm J E van Hulzen; A Marten H Onnink; Martine Hoogman; Tulio Guadalupe; Marcel Zwiers; Johanne M Groothuismink; Alicia Verberkt; Bonnie Nijhof; Anna Castells-Nobau; Stephen V Faraone; Jan K Buitelaar; Annette Schenck; Alejandro Arias-Vasquez; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-10       Impact factor: 3.568

Review 3.  Genetic basis of pain variability: recent advances.

Authors:  Erin E Young; William R Lariviere; Inna Belfer
Journal:  J Med Genet       Date:  2011-11-05       Impact factor: 6.318

4.  Polymorphisms in MC3R promoter and CTSZ 3'UTR are associated with tuberculosis susceptibility.

Authors:  Lindsey A Adams; Marlo Möller; Almut Nebel; Stefan Schreiber; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

5.  Children at risk for depression: memory biases, self-schemas, and genotypic variation.

Authors:  Lauren D Asarnow; Renee J Thompson; Jutta Joormann; Ian H Gotlib
Journal:  J Affect Disord       Date:  2014-02-19       Impact factor: 4.839

6.  MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.

Authors:  J M Mouton; L van der Merwe; A Goosen; M Revera; P A Brink; J C Moolman-Smook; C Kinnear
Journal:  Hum Genet       Date:  2016-03-11       Impact factor: 4.132

Review 7.  Genetic profiling and individualized assessment of fracture risk.

Authors:  Tuan V Nguyen; John A Eisman
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

8.  Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Authors:  Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

9.  Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy.

Authors:  Lize van der Merwe; Ruben Cloete; Miriam Revera; Marshall Heradien; Althea Goosen; Valerie A Corfield; Paul A Brink; Johanna C Moolman-Smook
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

10.  Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.

Authors:  Ignacio F Mata; Ali Samii; Seth H Schneer; John W Roberts; Alida Griffith; Berta C Leis; Gerard D Schellenberg; Ellen Sidransky; Thomas D Bird; James B Leverenz; Debby Tsuang; Cyrus P Zabetian
Journal:  Arch Neurol       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.